CONFERENCE OVERVIEW

Pioneering Diabetes Care in Asia

Bringing together premier endocrinologists, tech innovators, and researchers in Seoul.

LEADERSHIP & SCOPE
ESSENTIAL FACTS
CALL FOR ABSTRACTS

Call for Abstracts Open Soon

Submit original clinical, translational, or technological research for oral and e-poster presentations.

SESSIONS & FORMATS
SCIENTIFIC TRACKS
GLOBAL THOUGHT LEADERS

120+ International Faculty

Discover top researchers from Asia-Pacific, Europe, North America, and beyond.

CONFERENCE CHAIRS
COMMITTEES
JOIN US IN SEOUL

Save the Date: 10-12 Dec 2027

Join over 2,500 colleagues in dynamic Seoul. Pre-register for early-bird discounts.

DELEGATE REGISTRATION
TRAVEL & LOGISTICAL SUPPORT
VENUE & LODGING

COEX Convention Center, Gangnam

Experience modern facilities in the heart of Seoul with direct underground hotel access.

VENUE & DESTINATION
CITY EXPERIENCE
INDUSTRY OPPORTUNITIES

Partner with ATTD-ASIA 2027

Showcase your novel therapies and medical technologies to 2,500+ key Asian stakeholders.

COMMERCIAL OPPORTUNITIES
EXHIBITOR RESOURCES
TOOLKIT & PRESS

Promotional Toolkit Available

Download conference slides, email footers, and official graphics.

MEDIA & ASSETS
SCIENTIFIC ARCHIVES
DIGITAL ACADEMY

Year-Round Diabetes Education

Continuous professional development, accredited CME courses, and clinical masterclasses.

DIGITAL LEARNING
UPCOMING WEBINARS

DTT Journal & Abstracts

Diabetes Technology & Therapeutics

All submitted and accepted abstracts for ATTD-ASIA 2025 will be published together with the abstracts of the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2026) in the Diabetes Technology & Therapeutics journal (DTT), the official journal of ATTD, and will be available from 11 March 2026.

The Diabetes Technology & Therapeutics journal, led by Editor-in-Chief Satish K. Garg, MD, Diabetes Technology & Therapeutics, is the only peer-reviewed journal providing information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.

This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care.

  • To view the ATTD 2026 Abstracts published in the DTT Journal, click here to download (pdf file).
  • To view the ATTD 2025 Abstracts published in the DTT Journal, click here to download (pdf file).

Useful Links